Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.
|Published (Last):||10 August 2017|
|PDF File Size:||8.43 Mb|
|ePub File Size:||1.48 Mb|
|Price:||Free* [*Free Regsitration Required]|
Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia. Moreira C, Kaklamani V.
Predicting difficult intubation in apparently normal patients: Tiribelli M, Medeot M. Congestive heart cardiotoxkcidad and left ventricular dysfunction complicating doxorubicin therapy.
Recentemente, o estudo experimental de Casini S.
According to the study by Ayres et al 10about Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity. Int J Lab Hematol.
Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas
Docetaxel does not impair cardiac autonomic function in breast cancer patients previously treated with anthracyclines. Superior detection of cardiotoxicity during chemotherapy using biomarkers. Venous thromboembolism prophylaxis and treatment in cancer: Robson D, Verma S.
However, the toxicity is a major adverse effect of these agents, which may occur at any time in their administration or afterwards, especially when used in combination. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.
The role of catalase in pulmonary fibrosis. The analysis of the results of this retrospective study of the medical records of patients with HER2 positive breast cancer and the adverse reactions to the treatment with the monoclonal antibody Trastuzumab, concludes that the monitoring and notification of these adverse events, as well as the need for cardiological follow-up of these patients is of fundamental importance with a focus on the reduction of risks and the benefit of therapeutics.
There was a problem providing the content you requested
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel Taxol in a patient with metastatic ovarian carcinoma.
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. J Am Coll Cardiol. Cardiotoxicity induced by tyrosine kinase inhibitors. Cardiotoxicity of chemotherapeutic agents: Because they are specific target drugs, few studies are concerned with evaluating the possible oor events caused by these agents, often correlating with other clinical situations of cancer patients.
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Breast Cancer Res Treat. Based on data found in the research, a need to combine efforts among efforts among oncologists, cardiologists, nurses and clinical pharmacists was recognized, in order to identify these adverse events.
Guidelines on the trasguzumab and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.
Mechanical ventilation in the intraoperative period. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Korean J Intern Med.
I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia
Rev Bras Oncol Clin. Singal PK, Iliskovic N. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: Monoclonal antibodies are products based on modified immunoglobulins, which exert a specific effect on a specific target, which makes it one of the great bets in the treatment of certain tumors, as it decreases the adverse reactions caused by the antineoplastic chemotherapeutics.
Adverse reactions for the use of the monoclonal trastuzumab antibody in the treatment of patients with HER2 positive breast cancer.
Another reported constipation after the second cycle, abdominal pain after the 7th cycle and nausea after the 9th cycle and another patient presented odynophagia after the 5th cycle of Trastuzumab.
The results of surgery under general anesthesia in patients with lung cancer. Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis. High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant.
In order to inhibit the proliferation of cancer cells, the cell cycle is one of the main foci in the action of antineoplastic agents.